Fragransin B1

CAS No. 112516-03-7

Fragransin B1( —— )

Catalog No. M32417 CAS No. 112516-03-7

Fragransin B1 has antiprotozoal activity and is cytotoxic to rat myoblast L6 cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 551 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fragransin B1
  • Note
    Research use only, not for human use.
  • Brief Description
    Fragransin B1 has antiprotozoal activity and is cytotoxic to rat myoblast L6 cells.
  • Description
    Fragransin B1 has antiprotozoal activity and is cytotoxic to rat myoblast L6 cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    112516-03-7
  • Formula Weight
    404.5
  • Molecular Formula
    C22H28O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Molecules . 2020 Jun 19;25(12):2825.
molnova catalog
related products
  • PAR-3 (1-6) (human)

    PAR3 (1-6) is a synthetic peptide agonist of proteinase-activated receptor 1 (PAR1) that corresponds to residues 1-6 of the amino terminal tethered ligand sequence of human PAR3 and residues 39-44 of the full-length human sequence. PAR3 (1-6) activates p42/44 MAPK signaling in fibroblasts expressing PAR1, but not PAR3, an effect that can be blocked by the PAR1 antagonist RWJ 56110.

  • 4-Cyclohexylphenol

    4-Cyclohexylphenol is a biochemical compound for proteomics research.

  • CID1375606

    CID 1375606 is a surrogate agonist of orphan G protein-coupled receptor?GPR27. characterized by a high level of conservation among vertebrates and a predominant expression in the central nervous system.